P. Iyer

Radical prostatectomy versus observation for localized prostate cancer.

Timothy J Wilt, Michael J Barry, Steven Fox, 2012, The New England journal of medicine.

The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis.

Thomas E. Moritz, Lizy Thottapurathu, D. Reda, 2010, Urology.

The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.

T. Wilt, C. Roehrborn, M. Barry, 2009, Contemporary clinical trials.

Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy.

Thomas E. Moritz, D. Reda, H. Garewal, 2009, The Journal of urology.

Good tolerance to high‐dose hepatic arterial infusion therapy

A. Wile, P. Iyer, B. Kasimis, 1986, Journal of surgical oncology.

Comparative study of the clinical efficacy of two dosing regimens of flutamide.

P. Iyer, C. Bennett, McLeod Dg, 1999, Molecular urology.